Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoimmunity is a hallmark of post-COVID syndrome
Manuel Rojas, Yhojan Rodríguez, Yeny Acosta‐Ampudia, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
Claudia Kedor, Helma Freitag, Lil Meyer-Arndt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 219
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
Kiho Son, Rameen Jamil, Abhiroop Chowdhury, et al.
European Respiratory Journal (2022), pp. 2200970-2200970
Open Access | Times Cited: 161
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
Arneaux Kruger, Maré Vlok, Simone Turner, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 113
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity
Franziska Sotzny, Igor Salerno Filgueiras, Claudia Kedor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 72
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 72
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
Falko Tesch, Franz Ehm, Annika Vivirito, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2905-2914
Open Access | Times Cited: 71
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome
Suguru Saito, Shima Shahbaz, Xian Wu Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 32
Long COVID in pediatrics—epidemiology, diagnosis, and management
Nicole Toepfner, Folke Brinkmann, Silvia Augustin, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 4, pp. 1543-1553
Open Access | Times Cited: 18
Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome
Suguru Saito, Shima Shahbaz, Mohammed Osman, et al.
Journal of Autoimmunity (2024) Vol. 147, pp. 103267-103267
Open Access | Times Cited: 14
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 51
Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease
Idoia Busnadiego, Irène A. Abela, Pascal M. Frey, et al.
PLoS Biology (2022) Vol. 20, Iss. 7, pp. e3001709-e3001709
Open Access | Times Cited: 48
Molecular mimicry and autoimmunity in the time of COVID-19
Manuel Rojas, María Herrán, Carolina Ramírez‐Santana, et al.
Journal of Autoimmunity (2023) Vol. 139, pp. 103070-103070
Open Access | Times Cited: 36
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers
M.-K. Chung, Lanqi Gong, Dora Lai‐Wan Kwong, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 9
Open Access | Times Cited: 34
Post-COVID Syndrome in Adults—An Overview
Rüdiger E. Scharf, Juan‐Manuel Anaya
Viruses (2023) Vol. 15, Iss. 3, pp. 675-675
Open Access | Times Cited: 33
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review
Jacopo Ciaffi, Elena Vanni, Luana Mancarella, et al.
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1850-1850
Open Access | Times Cited: 26
Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation
T. Küchler, Roman Günthner, Andrea Ribeiro, et al.
Angiogenesis (2023) Vol. 26, Iss. 4, pp. 547-563
Open Access | Times Cited: 26
Autoimmunity in Long Covid and POTS
Fatema-Zahra El-Rhermoul, Artur Fedorowski, Philip Eardley, et al.
Oxford Open Immunology (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 25
Overview of autoantibodies in COVID‐19 convalescents
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Barbara Poniedziałek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 24
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
Francesco Ursini, Piero Ruscitti, Olga Addimanda, et al.
RMD Open (2023) Vol. 9, Iss. 2, pp. e003022-e003022
Open Access | Times Cited: 23
Increased incidence of rheumatoid arthritis after COVID-19
Juan Sebastián Marín, Enrique A. Mazenett-Granados, Juan Carlos Salazar, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 10, pp. 103409-103409
Open Access | Times Cited: 23
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
Dennyson Leandro M. Fonseca, Igor Salerno Filgueiras, Alexandre H. C. Marques, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Hematological alterations associated with long COVID-19
Guilherme C. Lechuga, Carlos Morel, Salvatore G. De-Simone
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 21
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
Paweł Kozłowski, Aleksandra Leszczyńska, Olga Ciepiela
American Journal of Medicine Open (2024) Vol. 11, pp. 100068-100068
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top